KNOWLEDGE BANK

Interviews

Engineering the Future of Pneumococcal Conjugate Vaccines (PCV)

PhD, Chemical and Biotechnology, Savitribai Phule Pune University. Manager-Manufacturing, Inventprise Inc
Walmik Karbhari Gaikwad PhD is a seasoned biopharmaceutical expert with years in vaccine RD and manufacturing His PhD research pioneered costeffective processes for pneumococcal conjugate vaccines holds scholarly publications international patents and serves on editorial boards Based in Seattle currently works on cGMPcompliant process development and production at Inventprise Inc

Articles

The Role of Technology in Continued Process Verification 4.0

The Quality Leaders in the Pharmaceutical Industry would feel no less than wearing a super hero cape if they had a mechanism to detect and resolve product quality issues before they even arise where they could monitor the processes in realtime and improve them where compliance is integrated into their daily manufacturing activities

Research Insights

Determining The Frequency Of Pathogenic Germline Variants From Exome Sequencing In Patients With Castrate-resistant Prostate Cancer

Abstract Objectives To determine the frequency of pathogenic inherited mutations in select genes from patients with metastatic castrateresistant prostate cancer mCRPC Design Observational Setting Multis

Case Studies

Isolation Technology: Case Study

A customer active in the hormone production recently searched an appropriate solution for grinding material and clean packaging after the filtering and drying process The following requirements had to be met To provide a safe barrier between the operator and the active drug substance to provide both operator and product protect

Techno Trends

First-of-its-Kind Setmelanotide Discovered for Hypothalamic Obesity

Rhythm Pharmaceuticals Inc discovers firstofitskind setmelanotide for the treatment of obesity Setmelanotide is not indicated for treating patients with suspected obesity due to POMC PCSK or LEPR deficiency with POMC PCSK or LEPR variants classified as benign or likely benign It is also not indicated for obesity related

White Papers

Cloud Computing in the Laboratory Informatics Solutions and Validation Approaches

In the modern business environment, a significant portion of work is conducted using computerized systems. Many solutions are used to complete tasks, including simple desktop programs like email and Microsoft Office to enterprise-wide, global systems like ERP (Enterprise Resource Planning), MES (Manufacturing Execution System), and LIMS

TOP ARTICLES

1

Detangling the Diagnostic Odyssey in Neurodevelopmental Disorder by Genomic Consultancy

Emili Banerjee Bhattacharjee

Emili is a well-known genetic consultant with vast experience in cytogenetics, molecular biology with special emphasis in neurobiology. She is doing human genetics for past 22 years and now is practising genetic counselling as well as continuing her passion for research.

 

Koutilya Bhattacharjee

Koutilya basically is an academician in Zoology and has research interest in areas like anti-microbial peptides of amphibians, bio-active components of amphibians and genetic aspects of human reproductive disorder.

 

2

Current Research on Plant miRNA and Its Application in Disease Prevention

Atiyabanu N Saiyed

Atiya Saiyed is a Ph D student at Iladevi Cataract and IOL Research Centre and registered at Manipal Academy of Higher Education, Manipal. She is Senior Research Fellow from Indian Council of Medical Research, New Delhi. Atiya does research in the fields of molecular biology, cell biology, and cancer biology.

 

Abhay R. Vasavada

Abhay R. Vasavada is a well-known ophthalmologist who founded Raghudeep Eye Clinic (REH) and Iladevi Cataract and IOL Research Centre (ICIRC) in Ahmedabad, India. In 2011, the American Society of Cataract and Refractive Surgeons (ASCRS) gave him the Binkhorst Medal Lecture, making him the first Indian and just the second Asian to get the honour. He has almost 140 publications to his credit.

 

Kaid Johar SR

Kaid Johar SR is an Associate Professor in Department of Zoology and Biomedical TechnologyGujarat University, who specialized in cell and molecular biology, ophthalmology, cancer, and toxicology. He has almost 50 publications in prestigious journals.

 

3

Synbiotics in Metabolic Health

Dr. Neeraj Mishra

Dr. Neeraj Mishra is working as Professor and Head, Department of Pharmaceutics,  in Amity Institute of Pharmacy, Gwalior since July 2019. He has around twenty years of teaching and research experience.  He has more than 100 publications of International and National repute in recent concepts of novel drug delivery systems, localised drug delivery, targeted and controlled drug delivery of nanocarriers/ microparticles for the treatment of breast, colon cancer, and neurodegenerative disorders. Dr. Mishra more than 3700 citations with h- index 32. The total cumulative Impact Factor of his published papers is more than 300 (as per SCOPUS). He has also written 15 Books and 30 book chapters in Elsevier, Bentham, Springer and Wiley Publication etc. He has also been granted 3 international patents and 2 Indian patents.  Dr. Mishra is recipient of “Distinguished Professor Award” 2019 from DST-NSTMIS, SPAICS, Indore, and M.P. in September 2019.  Dr. Mishra has received the “Distinguished Professor Award '' 2021 from Indian Pharmaceutical Association, MP State Branch, Indore.  Dr Mishra has received Best Academician Award in the Indian Pharmacy Graduate Association, M.P. State International Conference held on 06th May 2023 at DAVV Auditorium, Indore, India.

Devyani Rajput

Dr. Devyani Rajput is working as an Assistant Professor, Department of Pharmacognosy, in Amity Institute of Pharmacy, Gwalior since Jan 2024. She has around seven years of research experience. Her expertise includes nanotechnology, phytomedicine, and advanced drug delivery systems, with notable contributions to cancer research. She has participated in various national and international conferences, published impactful research, and received prestigious awards, including the BEST SCHOLAR AWARD 2023. She has more than 150 citations with h- index 3. She has received the CSIR travel Grant in April 2024 for presenting her research work in Istanbul University.

4

Current Challenges in Fully Digitising Manufacturing for Biotech and Cell and Gene Therapy Companies

Abhijit Ray

Abhijit has led teams for large enterprises helping them take their performance to the cloud. He has implemented AI/ML solutions, IoT frameworks, and cloud infrastructure.

 

5

3-dimensional Bioprinting of Tissue and Organs From bench to bedside

Ryan Varghese

Ryan Varghese is a student and researcher affiliated with the Department of Pharmaceutical Chemistry, Poona College of Pharmacy, India. His work spans a spectrum of topics from artificial intelligence to cancer theranostics and drug delivery in Alzheimer's disease.His specialisation lies in the drug delivery modalities in chronic diseases. He has curated several articles on the lacunae in the Government public policies while providing solutions for the same. His recent works include the proposal of drug repurposing and affordable hospitalisation to mitigate the risk stemming from COVID-19 in India.

 

Sahil Salvi

Sahil Salvi is a student and researcher associated with the Department of Pharmaceutical Chemistry, Poona College of Pharmacy, India. His works spans across a broad variety of topics, with specialisations in drug delivery and pharmaceutics, especially in chronic diseases. His keen interest in the latter has driven him to curate scientific articles in pharmaceutics and pharmacology.

 

Dileep Kumar

Dileep Kumar is an assistant professor in the Department of Pharmaceutical Chemistry at Poona College of Pharmacy. He is a pioneer in his field with his forte in the treatment and novel drug delivery in Cancer and Alzheimer’s disease, especially adamantyl analogs as GluN2B selective NMDA receptor agonists. He is also an awardee of the Junior Research Fellowship from the National Medicinal Plant Board (NMPB) New Delhi, Senior Research Fellowship from the University Grants Commission (UGC), Teaching Assistantship, and Institute Post-Doctoral Fellowship from IIT (BHU) Varanasi. He is the Guest editor of Prestigious journals like Current Topics in Medicinal Chemistry, CTMC, Current drug target, combinatorial chemistry, and molecules.

press releasesRead more...

Lonza Expands Strategic Collaboration with Leading US Biopharmaceutical Company

Lonza the worlds leading contract development and manufacturing organization CDMO today announced an expanded strategic collaboration with a leading USbased biopharmaceutical company

Cartherics recognised as Asia Pacific Emerging Leader in Allogeneic Cell Therapy

Cartherics Pty Ltd Cartherics or Company a biotechnology company developing offtheshelf immune cell therapies focusing on highimpact womens diseases with lead programs in ovarian cancer and endometriosis

Icosagen completes €45 million expansion, bringing therapeutic protein discovery, development and GMP manufacturing together under one roof

Estoniabased biotechnology company Icosagen has completed a major strategic expansion to strengthen its integrated biologics development and manufacturing capabilities at a single site creating a seamless pathway

AGC Biologics Expands to Fill-Finish in U.S. Through Strategic Partnership with Pyramid Pharma Services

Drug developers have a new optimized option for USbased manufacturing as AGC Biologics enters a strategic partnership with Pyramid Pharma Services The collaboration combines AGC Biologics expertise

Vect-Horus announces collaboration and license option agreement with Servier to develop targeted oligonucleotide therapeutics for rare CNS diseases

VectHorus a privately held biotechnology company that designs and develops molecular vectors facilitating the targeted delivery of therapeutic molecules and imaging agents announces a research evaluation and exclusive

FDA grants Priority Review to Roche’s Enspryng, the first and only at-home subcutaneous treatment option for thyroid eye disease (TED)

Roche announced today that the US Food and Drug Administration FDA has accepted and granted priority review to a supplemental Biologics License Application sBLA for Enspryng satralizumab

EventsRead more...

07 - 09

Jul 2026

The Pharma India Expo 2026

Bombay Exhibition Centre, Mumb...

07 - 09

Jul 2026

08 - 10

Jul 2026

CPHI SEA 2026

QSNCC, Bangkok, Thailand

09 - 11

Jul 2026

Pharma Pro&Pack Expo 2026

HITEX Exhibition Centre, Hyder...

16 - 19

Jul 2026

Bio Asia Taiwan 2026

Taipei Nangang Exhibition Cent...

20 - 22

Jul 2026

6th mRNA-Based Therapeutics Summit

The Westin Boston Seaport Dist...

20 - 22

Jul 2026

24 - 25

Jul 2026

LATEST NEWSRead more...

Viva Biotech and Adjutor Group Partner to Expand Global Drug Development Services

Viva Biotech and Adjutor Group have announced a collaboration aimed at expanding their international business networks and strengthening engagement with global life sciences partners

Excalipoint Therapeutics partners with Roche to evaluate EXP011 in DLL3-expressing solid tumours

Excalipoint Therapeutics has entered into a clinical trial collaboration with Roche to evaluate its lead product candidate EXP CTM in combination with atezolizumab for the treatment of DLLexpressing solid tumours

Innovent Biologics and Lilly sign commercialisation agreement for Verzenios in mainland China

Innovent Biologics and Eli Lilly and Company have signed a distribution and promotion agreement for Verzenios abemaciclib in mainland China

Roche launches AXELIOS 1 next-generation sequencing platform

Roche has launched AXELIOS its nextgeneration sequencing platform powered by proprietary Sequencing by Expansion SBX technology The new system combines high accuracy rapid sequencing flexibility

Ipsen to acquire Kartos Therapeutics, expanding late-stage haemato-oncology pipeline

Ipsen has entered into a definitive merger agreement to acquire Kartos Therapeutics strengthening its latestage haematooncology pipeline The acquisition adds navtemadlin an investigational MDM inhibitor

Ionis Licenses Zilganersen Rights Outside US to Recordati

Ionis Pharmaceuticals has signed a licensing agreement with Recordati granting the company exclusive rights to develop and commercialise the investigational medicine zilganersen for Alexander disease AxD